The measurement of quality of life in hypertensive patients: a practical approach.

Bulpitt, C J; Fletcher, A. E.

doi:10.1111/j.1365-2125.1990.tb03784.x

Cited by 79 publications

(49 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The first questionnaire was a validated Dutch version of a questionnaire for recording physical symptoms associated with hypertension or antihypertensive treatment and the effect of treatment on lifestyle. 12,13 The second questionnaire was a validated Dutch version of the 'MOS Short-form General Health Survey' (MOS Survey). 14,15 This generic health questionnaire measures six dimensions of quality of life: physical functioning, role functioning, social functioning, psychological wellbeing, health perceptions, and pain.…”

Section: Quality Of Lifementioning

confidence: 99%

The effect of treatment on health-related quality of life in patients with hypertension and renal artery stenosis

et al. 2005

View full text Add to dashboard Cite

The quality of life in patients with hypertension is considered to be impaired mainly by side effects of antihypertensive drug therapy. Since balloon angioplasty for renal artery stenosis has a medication-sparing effect, it may lead to an improvement in quality of life. The objective of the study is to compare the effect of antihypertensive drug therapy and balloon angioplasty on quality of life in patients with hypertension and renal artery stenosis. We compared the quality of life in 56 patients randomised to balloon angioplasty to that in 50 patients randomised to antihypertensive drug therapy after 3 and 12 months of follow-up. Quality of life was measured using a questionnaire on physical symptoms associated with hypertension and antihypertensive drugs, and two generic health questionnaires (MOS Survey and EuroQol instrument). After follow-up, the patients who underwent angioplasty used less antihypertensive drugs than the patients who were treated with antihypertensive drugs only (mean7s.d., 1.970.9 vs 2.571.0 drugs after 3 months, P ¼ 0.002). They reported similar physical complaints, however, and a similar quality of life. The results after 12 months of follow-up were the same. In conclusion, for patients with hypertension and renal artery stenosis, the decrease in antihypertensive medication after intervention is too small to lead to a detectable improvement in quality of life.

show abstract

Section: Quality Of Lifementioning

confidence: 99%

The effect of treatment on health-related quality of life in patients with hypertension and renal artery stenosis

et al. 2005

View full text Add to dashboard Cite

show abstract

“…28 This questionnaire scores for seven variables: health status index (HSI), total psychiatric morbidity, anxiety, depression, somatic symptoms, cognitive symptoms and hostility. Except for HSI, a lower score indicates a better quality of life.…”

Section: Methodsmentioning

confidence: 99%

Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide

et al. 1999

View full text Add to dashboard Cite

“…(g) Symptom assessment 5 Thirty-four symptoms were assessed including those associated with hypertension and those occurring as side effects of treatment. Thirty-four were assessed in men and 32 in women.…”

Section: (F) Profile Of Mood States (Poms)mentioning

confidence: 99%

“…The HSI is computed from answers to the SIP and other questions and modified according to the symptom complaint rate. 5,11 Quality control of the questionnaires was performed centrally by the Epidemiology Research Unit based at the Hammersmith Hospital Campus. One centre was removed from the study as the questionnaires were given to the patients to complete and the information was not collected by an interviewer.…”

Section: (H) Health Status Index (Hsi)mentioning

confidence: 99%

“…Individual symptoms were not reported in this trial but the overall complaint rate was incorporated in the HSI. 4,5 However the relative merits of the two drugs have not been established and we report the results of a large trial performed by the European Bisoprolol Trial Investigators to compare bisoprolol with nifedipine retard. 6 It is also widely believed that beta-blockers may have additional benefits in reducing anxiety and tension.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life

et al. 2000

Self Cite

View full text Add to dashboard Cite

Subjects over the age 60 with sustained sitting diastolic pressures of 95-115 mm Hg were randomised to a regime based on bisoprolol (n ‫؍‬ 368) or nifedipine retard (n ‫؍‬ 379) for 24 weeks. The goal diastolic pressure was р90 mm Hg and to achieve this, double-blind medication could be doubled (5/10 mg bisoprolol, 40/80 mg nifedipine retard) or hydrochlorothiazide 25 mg (unblinded) could be added to the higher dose. In an intention-to-treat analysis, 309 subjects in both the bisoprolol and nifedipine retard treated group provided at least a baseline and a second quality of life assessment (82%). An excess of symptoms was observed in the nifedipine group for oedema of the legs, nocturia, constipation, racing heart and heart thumping. Fewer patients reported wheeze in the nifedipine group. For

show abstract

The measurement of quality of life in hypertensive patients: a practical approach.

Cited by 79 publications

References 16 publications

The effect of treatment on health-related quality of life in patients with hypertension and renal artery stenosis

The effect of treatment on health-related quality of life in patients with hypertension and renal artery stenosis

Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide

Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life

Contact Info

Product

Resources

About